| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.921681 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240521150938 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 230414e20240521onc ob f000 0 eng d |
|---|
| 020 | |a9780660483740 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-49/2024E-PDF |
|---|
| 245 | 00|aAnnex 1 to the Good manufacturing practices guide : |bmanufacture of sterile drugs (GUI-0119). |
|---|
| 250 | |aVersion 2. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada,|c21 May, 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (84 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Annexe 1 des Lignes directrices sur les bonnes pratiques de fabrication : fabrication de médicaments stériles (GUI-0119). |
|---|
| 500 | |a"Replaces: Annex 1 to the Good manufacturing practices guide: Manufacture of sterile drugs (GUI-0119), February 28, 2018." |
|---|
| 504 | |aIncludes bibliographical references (page 81). |
|---|
| 520 | |a"This document provides guidance for fabricating and packaging/labelling sterile drugs"--Purpose, page 5. |
|---|
| 650 | 0|aDrug factories|zCanada. |
|---|
| 650 | 0|aDrugs |xSterilization|zCanada. |
|---|
| 650 | 0|aDrugs|xLabeling|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tAnnexe 1 des Lignes directrices sur les bonnes pratiques de fabrication : |w(CaOODSP)9.921682 |
|---|
| 856 | 40|qPDF|s820 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H139-49-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-annex-1-manufacture-sterile-drugs-0119.html |
|---|
| 986 | |a240207 |
|---|